Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20266 Citations
Svetinorm6 residuesAEDLPGEach bubble = one amino acid. Size = residue mass. Color = chemical class.Svetinorm is a Khavinson oral liver bioregulator containing peptide complex A-7. One clinical study (n=47) showed ALT and bilirubin stabilization in hepatitis patients. No RCTs exist. Capsule dosing runs 10 to 20 mg daily for 30-day courses, repeated two to three times yearly.
10mcg · Daily
Summary: Add 0mL BAC water to your 20mg vial. Draw to < 0.1 units on a U-100 syringe for a 10mcg dose. This vial will last 0 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 10mg | Daily |
| Moderate | 10mg | 2x Daily |
| Aggressive | 20mg | 2x Daily |
Svetinorm ships as oral capsules. No reconstitution, no syringes, no bacteriostatic water. Each capsule contains 10 mg of peptide complex A-7. Bottles come in 20-cap and 60-cap sizes. A 60-cap bottle covers one full 30-day course at 2 caps per day. The 20-cap bottle only lasts 10 days at that dose, so you'll need three of them for a complete course. Take capsules with meals. The manufacturer and the Khavinson protocol both specify mealtime dosing; empty-stomach use is the main trigger for the mild GI discomfort some users report. Get a liver panel (ALT, AST, bilirubin) before your first capsule. Get another at the end of the 30-day course. Without those two data points, you're flying blind on whether anything actually changed. The off-period matters. Four to six months between courses is not a suggestion; it's the core premise of the bioregulator approach. KEDA triggers epigenetic changes that are supposed to persist after the compound clears. Restarting early undermines the protocol's theoretical basis.
Dosing based on Khavinson Institute protocol — 9 published references.View all sources →
Cross-check your Svetinorm reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Svetinorm is a Khavinson oral liver bioregulator containing peptide complex A-7. One clinical study (n=47) showed ALT and bilirubin stabilization in hepatitis patients. No RCTs exist. Capsule dosing runs 10 to 20 mg daily for 30-day courses, repeated two to three times yearly.
